Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Zonneveld, Rens ^a,b,c   Martinelli, Roberta ^b   Shapiro, Nathan I ^b   Kuijpers, Taco W ^c   Plötz, Frans B ^a   Carman, Christopher V ^b  

^a Tergooi Hospitals   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE;

ADULT; AGE; BLOOD; CHILD; HUMAN; NEWBORN; PATHOPHYSIOLOGY; SEPSIS; SOLUBILITY;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CHILD; HUMANS; INFANT, NEWBORN; SEPSIS; SOLUBILITY;

EID: 84894039540     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13733     Document Type: Review

References (92)

1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, Surviving Sepsis Campaign Management Guidelines Committee Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873. 10.1097/01.CCM.0000117317.18092.E4, 15090974, Surviving Sepsis Campaign Management Guidelines Committee.
2. Lukacs SL, Schoendorf KC, Schuchat A. Trends in sepsis-related neonatal mortality in the United States. 1985-1998. Pediatr Infect Dis J 2004, 23:599-603. 10.1097/01.inf.0000131633.74921.90, 15247595.
3. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID, Hale EC, Shankaran S, Kennedy K, Carlo WA, Watterberg KL, Bell EF, Walsh MC, Schibler K, Laptook AR, Shane AL, Schrag SJ, Das A, Higgins RD, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Early onset neonatal sepsis: the burden of group B-streptococcal and E. coli disease continues. Pediatrics 2011, 127:817-826. 10.1542/peds.2010-2217, 3081183, 21518717, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
5. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
6. Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, Trzeciak S, Ngo L, Aird WC. The association of endothelial cell signalling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010, 14:R182. 10.1186/cc9290, 3219288, 20942957.
7. Carman CV, Springer TA. Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 2008, 20:533-534. 10.1016/j.ceb.2008.05.007, 2811962, 18595683.
8. Springer TA. Adhesion receptors of the immune system. Nature 1990, 346:425-433. 10.1038/346425a0, 1974032.
9. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell 1994, 76:301-314. 10.1016/0092-8674(94)90337-9, 7507411.
10. Garton KJ, Gough PJ, Raines EW. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 2006, 79:1105-1116. 10.1189/jlb.0106038, 16565325.
11. Xing K, Murthy S, Liles WC, Singh JM. Clinical utility of biomarkers of endothelial activation in sepsis - a systematic review. Crit Care 2012, 16:R7. 10.1186/cc11145, 3396237, 22248019.
12. Long C, Wang Y, Herrera AH, Horiuchi K, Walcheck B. In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J Leukoc Biol 2010, 87:1097-1101. 10.1189/jlb.1109763, 2872538, 20154226.
13. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689. 10.1038/nri2156, 17717539.
14. Harrington EO, Stefanec T, Newton J, Rounds S. Release of soluble E-selectin from activated endothelial cells upon apoptosis. Lung 2006, 184:259-266. 10.1007/s00408-005-2589-5, 17235725.
15. Pigot R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biophys Res Commun 1992, 187:584-589.
16. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993, 150:644-654.
17. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997, 156:431-437. 10.1164/ajrccm.156.2.9509017, 9279220.
18. Smith CW. Potential significance of circulating E-selectin. Circulation 1997, 95:1986-1988. 10.1161/01.CIR.95.8.1986, 9133502.
19. Briassoulis G, Papassotiriou I, Mavrikiou M, Lazaropoulou C, Margeli A. Longitudinal course and clinical significance of TGF-beta1, sL- and sE-Selectins and sICAM-1 levels during severe acute stress in children. Clin Biochem 2007, 40:299-304. 10.1016/j.clinbiochem.2006.11.015, 17291476.
20. Smalley DM, Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 2005, 9:255-266. 10.1111/j.1582-4934.2005.tb00354.x, 15963248.
21. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, Oshel P, Bock CB, Miller AS, Albrecht RM, Kubes P, Steeber DA, Tedder TF. Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 2003, 19:713-724. 10.1016/S1074-7613(03)00295-4, 14614858.
22. Seidelin JB, Nielsen OH, Strøm J. Soluble L-selectin levels predict survival in sepsis. Intensive Care Med 2002, 28:1613-1618. 10.1007/s00134-002-1501-5, 12415449.
23. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992, 119:229-238. 10.1083/jcb.119.1.229, 2289629, 1382078.
24. Ferri LE, Pascual J, Seely AJ, Chaudhury P, Christou NV. Soluble L-selectin attenuates tumor necrosis factor-α-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis. Crit Care Med 2002, 30:1842-1847. 10.1097/00003246-200208000-00028, 12163803.
25. Ferri LE, Swartz D, Christou NV. Soluble L-selectin at levels present in septic patients diminishes leukocyte-endothelial cell interactions in mice in vivo: a mechanism for decreased leukocyte delivery to remote sites in sepsis. Crit Care Med 2001, 29:117-122. 10.1097/00003246-200101000-00024, 11176170.
26. Ferri LE, Chia S, Benay C, Giannias B, Christou NV. L-selectin shedding in sepsis limits leukocyte mediated microvascular injury at remote sites. Surgery 2009, 145:384-391. 10.1016/j.surg.2008.12.011, 19303986.
27. Easton AS, Dorovini-Zis K. The kinetics, function, and regulation of P-selectin expressed by human brain microvessel endothelial cells in primary culture. Microvasc Res 2001, 62:335-345. 10.1006/mvre.2001.2350, 11678636.
28. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil interactions: linking haemostasis and inflammation. Blood Rev 2007, 21:99-111. 10.1016/j.blre.2006.06.001, 16987572.
29. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997, 77:1081-1085.
30. Chen AY, Ha JN, Delano FA, Schmid-Schönbein GW. Receptor cleavage and P-selectin-dependent reduction of leukocyte adhesion in the spontaneously hypertensive rat. J Leukoc Biol 2012, 92:183-194. 10.1189/jlb.0112010, 3382314, 22566571.
31. Füth R, Dinh W, Nickl W, Bansemir L, Barroso MC, Bufe A, Sause A, Scheffold T, Krahn T, Ellinghaus P, Lankisch M. Soluble P-selectin and matrix metalloproteinase 2 levels are elevated in patients with diastolic dysfunction independent of glucose metabolism disorder or coronary artery disease. Exp Clin Cardiol 2009, 14:76-79.
32. Mosad E, Elsayh KI, Eltayeb AA. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy. Clin Appl Thromb Hemost 2011, 17:80-87. 10.1177/1076029609344981, 19689998.
33. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 2006, 281:3157-3164. 10.1074/jbc.M510797200, 16332693.
34. Sultan S, Gosling M, Nagase H, Powell JT. Shear stress-induced shedding of soluble intercellular adhesion molecule-1 from saphenous vein endothelium. FEBS Lett 2004, 564:161-165. 10.1016/S0014-5793(04)00337-0, 15094060.
35. Fiore E, Fusco C, Romero P, Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 2002, 21:5213-5223. 10.1038/sj.onc.1205684, 12149643.
36. Champagne B, Tremblay P, Cantin A, St Pierre Y. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol 1998, 161:6398-6405.
37. van Griensven M, Probst C, Müller K, Hoevel P, Pape HC. Leukocyte-endothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis. Shock 2006, 25:254-259. 10.1097/01.shk.0000196497.49683.13, 16552357.
38. Shapiro NI, Yano K, Sorasaki M, Fischer C, Shih SC, Aird WC. Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis. J Vasc Res 2009, 46:495-502. 10.1159/000210662, 19346756.
39. Lemaire LC, de Kruif MD, Giebelen IA, van Zoelen MA, van't Veer C, van der Poll T. Differential dose-dependent effects of prednisolone on shedding of endothelial adhesion molecules during human endotoxemia. Immunol Lett 2008, 21:93-96.
40. Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R, Knauper V, Murphy G, Gavrilovic J. Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res 2005, 67:39-49. 10.1016/j.cardiores.2005.02.020, 15949468.
41. Newby AC. Studying mechanisms underlying shedding of endothelial membrane proteins could help patients at risk for myocardial infarction. Cardiovasc Res 2005, 67:4-5. 10.1016/j.cardiores.2005.04.024, 15907817.
42. Koenig JM, Simon J, Anderson DC, Smith E, Smith CW. Diminished soluble and total cellular L-selectin in cord blood is associated with its impaired shedding from activated neutrophils. Pediatr Res 1996, 39:616-621. 10.1203/00006450-199604000-00009, 8848334.
43. Rebuck N, Gibson A, Finn A. Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding. Clin Exp Immunol 1995, 101:183-189. 1553291, 7542575.
44. Török C, Lundahl J, Hed J, Lagercrantz H. Diversity in regulation of adhesion molecules (Mac-1 and L-selectin) in monocytes and neutrophils from neonates and adults. Arch Dis Child 1993, 68:561-565. 10.1136/adc.68.5_Spec_No.561, 1029303, 7686738.
45. Austgulen R, Arntzen KJ, Haereid PE, Aag S, Døllner H. Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selectin. Acta Pediatr 1997, 86:274-280.
46. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390. 10.1038/nri2075, 17457344.
47. Giannaki G, Rizos D, Xyni K, Sarandakou A, Protonotariou E, Phocas I, Creatsas G. Serum soluble E-and L-selectin in the very early neonatal period. Early Hum Develop 2000, 60:149-155.
48. Sitaru AG, Speer CP, Holzhauer S, Obergfell A, Walter U, Grossmann R. Chorioamnionitis is associated with increased CD40L expression on cord blood platelets. Thromb Haemost 2005, 94:1219-1223.
49. Figueras-Aloy J, Gómez-López L, Rodríguez-Miguélez JM, Salvia-Roiges MD, Jordán-García I, Ferrer-Codina I, Carbonell-Estrany X, Jiménez-González R. Serum soluble ICAM-1, VCAM-1, L-selectin and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. Am J Perinat 2007, 24:331-338.
50. Kourtis AP, Lee FK, Stoll BJ. Soluble L-selectin, a marker of immune activation, in neonatal infection. Clin Immunol 2003, 109:224-228. 10.1016/S1521-6616(03)00209-2, 14597221.
51. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, Richter K, Tawfeek MS, Clad A, Brandis M. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-(alpha), interleukin (IL)-1(beta), IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998, 44:469-477. 10.1203/00006450-199810000-00002, 9773833.
52. Dollner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumor necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001, 54:1251-1257. 10.1016/S0895-4356(01)00400-0, 11750194.
53. Hansen AB, Verder H, Staun-Olsen P. Soluble intercellular adhesion molecule and C-reactive protein as early markers of infection in newborns. J Perinat Med 2000, 28:97-103.
54. Edgar JDM. Serum sICAM-1 levels in the diagnosis of neonatal infection. Pediatr Res 1998, 44:430.
55. Edgar JDM, Wilson DC, McMillan SA, Crockard AD, Halliday MI, Gardiner KR, Rowlands BJ, Halliday HL, McNeill TA. Predictive value of soluble immunological mediators in neonatal infection. Clin Sci 1994, 87:165.
56. Edgar JDM, Gabriel V, Craig A, Wheeler D, Thomas M, Grant J. A low serum sICAM-1 level may assist in the exclusion of neonatal infection. Biol Neonate 2002, 81:105-108. 10.1159/000047193, 11844879.
57. Edgar JDM, Gabriel V, Gallimore JR, McMillan SA, Grant J. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr 2010, 16:10-22.
58. Apostolou M, Dimitriou H, Kaleyias J, Perdikogianni C, Stiakaki E, Costalos C, Kalmanti MC. Levels of soluble ICAM-1 in premature and full-term neonates with infection. Mediators Inflamm 2002, 11:95-98. 10.1080/09629350220131944, 1781652, 12061430.
59. Kourtis AP, Nesheim SR, Thea D, Ibegbu C, Nahmias AJ, Lee FK. Correlation of virus load and soluble L-selectin, a marker of immune activation, in pediatric HIV infection. AIDS 2000, 14:2429-2436. 10.1097/00002030-200011100-00003, 11101052.
60. Andrys C, Pozler O, Krejsek J, Derner V, Drahosová M, Kopecký O. Serum soluble adhesion molecules (sICAM-1, sVCAM and E-selectin) in healthy school aged children and adults. Acta Medica (Hradec Kralove) 2000, 43:103-106.
61. Paize F, Sarginson R, Makwana N, Baines PB, Thomson AP, Sinha I, Hart CA, Riordan A, Hawkins KC, Carrol ED, Parry CM. Changes in the sublingual microcirculation and endothelial adhesion molecules during the course of severe meningococcal disease treated in the paediatric intensive care unit. Intensive Care Med 2012, 38:863-871. 10.1007/s00134-012-2476-5, 22398755.
62. Krueger M, Heinzmann A, Nauck M. Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome. Int Care Med 2007, 33:359-363.
63. Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, Kochanek PM, Carcillo JA. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med 2000, 28:2600-2607.
64. Nash MC, Wade AM, Shah V, Dillon MJ. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996, 103:167-170. 10.1046/j.1365-2249.1996.925616.x, 2200316, 8565278.
65. Presterl E, Lassnigg A, Mueller-Uri P, El-Menyawi I, Graninger W. Cytokines in sepsis due to Candida albicans and in bacterial sepsis. Eur Cytokine Netw 1999, 10:423-430.
66. Weigand MA, Schmidt H, Pourmahmoud M, Zhao Q, Martin E, Bardenheuer HJ. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 1999, 27:2656-2661. 10.1097/00003246-199912000-00008, 10628605.
67. Hynninen M, Valtonen M, Markkanen H, Vaara M, Kuusela P, Jousela I, Piilonen A, Takkunen O. Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care 1999, 14:63-68. 10.1016/S0883-9441(99)90015-1, 10382785.
68. Knapp S, Thalhammer F, Locker GJ, Laczika K, Hollenstein U, Frass M, Winkler S, Stoiser B, Wilfing A, Burgmann H. Prognostic value of MIP-1α, TGF-β2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immunol Immunopathol 1998, 7:139-144.
69. Osmanovic N, Romijn FP, Joop K, Sturk A, Nieuwland R. Soluble selectins in sepsis: microparticle-associated, but only to a minor degree. Thromb Haemost 2000, 84:731-732.
70. Soderquist B, Sundqvist KG, Vikerfors T. Adhesion molecules E-selectin, intercellular adhesion molecules-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in sera from patients with Staphylococcus aureus bacteremia with or without endocarditis. Clin Exp Immunol 1999, 118:408-411. 10.1046/j.1365-2249.1999.01081.x, 1905434, 10594559.
71. Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, Karonen SL, Repo H. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond) 1999, 97:529-538.
72. Geppert A, Zorn G, Karth GD, Haumer M, Gwechenberger M, Koller-Strametz J, Heinz G, Huber K, Siostrzonek P. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med 2000, 28:2360-2365.
73. De Pablo R, Monserrat J, Reyes E, Diaz D, Rodriguez-Zapata M, de la Hera A, Prieto A, Alvarez-Mon M. Circulating sICAM-1 and sE-selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome. Eur J Intern Med 2013, 24:132-138. 10.1016/j.ejim.2012.10.009, 23352000.
74. Kayal S, Jaïs JP, Aguini N, Chaudière J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998, 157:776-784. 10.1164/ajrccm.157.3.9705034, 9517590.
75. Doughty LA, Kaplan SS, Carcillo JA. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 1996, 24:1137-1143. 10.1097/00003246-199607000-00012, 8674325.
76. Leone M, Boutière B, Camoin-Jau L, Albanèse J, Horschowsky N, Mège JL, Martin C, Dignat-George F. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002, 30:808-814. 10.1097/00003246-200204000-00015, 11940750.
77. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006, 34:532-537. 10.1097/01.CCM.0000198525.82124.74, 16424738.
78. Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin E, Hoffmann U, Weigand MA. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 2009, 13:R93. 10.1186/cc7923, 2717465, 19538738.
79. Rudloff S, Thomas C, Kunz C. Variations of soluble intercellular cell adhesion molecule. Eur J Med Res 1995, 1:171-172.
80. Gearing JH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993, 14:506-512. 10.1016/0167-5699(93)90267-O, 7506035.
81. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care Med 2010, 14:15.
82. Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis related hypotension. Shock 2011, 36:104-108. 10.1097/SHK.0b013e31821e4e04, 3139767, 21522043.
83. Donnelly SC, Haslett C, Robertson CE, Carter DC, Ross JA, Grant IS, Tedder TF. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994, 344:215-219. 10.1016/S0140-6736(94)92995-5, 7518025.
84. Hoffmann U, Brueckmann M, Borggrefe M. Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?. Crit Care 2009, 13:1006. 10.1186/cc8156, 2811909, 20017890.
85. Lauhio A, Hästbacka J, Pettilä V, Tervahartiala T, Karlsson S, Varpula T, Varpula M, Ruokonen E, Sorsa T, Kolho E. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011, 64:590-594. 10.1016/j.phrs.2011.06.019, 21742038.
86. Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, Orbe J, Rodríguez JA, Jiménez A, Borreguero-León JM, Belmonte F, Medina JC, Llimiñana MC, Ferrer-Agüero JM, Ferreres J, Mora ML, Lubillo S, Sánchez M, Barrios Y, Sierra A, Páramo JA. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009, 13:R158. 10.1186/cc8115, 2784384, 19799791.
87. Yazdan-Ashoori P, Liaw P, Toltl L, Webb B, Kilmer G, Carter DE, Fraser DD. Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis. J Crit Care 2011, 26:556-565. 10.1016/j.jcrc.2011.01.008, 21439766.
88. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998, 4:615-618. 10.1038/nm0598-615, 9585238.
89. Long C, Hosseinkhani MR, Wang Y, Sriramarao P, Walcheck B. ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment. J Leukoc Biol 2012, 92:667-672. 10.1189/jlb.0312112, 3427607, 22623356.
90. Bonnema DD, Webb CS, Pennington WR, Stroud RE, Leonardi AE, Clark LL, McClure CD, Finklea L, Spinale FG, Zile MR. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail 2007, 13:530-540. 10.1016/j.cardfail.2007.04.010, 2698433, 17826643.
91. Tayebjee MH, Lip GY, Blann AD, Macfadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005, 115:205-210. 10.1016/j.thromres.2004.08.023, 15617743.
92. Graves BT, Munro CL. Epigenetics in critical illness: a new frontier. Nurs Res Pract 2013, 2013:503686. 3723097, 23936643.